Saluda Medical closes $100M financing

Saluda Medical closed a $100 million finance round, the spine company said Jan. 10.

Advertisement

Financing was led by Redmile Group and other existing investors, according to a news release. The money will support commercialization of the Evoke closed-loop spinal cord stimulator.

Saluda’s Evoke system is the first designed to sense and measure neural responses and automatically adjust therapy. 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.